Reductions in HbA1c and Weight in Type 2 Diabetics with the Empagliflozin Add-On Regimen

Article Information

DOI 
http://dx.doi.org/10.1177/155989771420009
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2014 MD Conference Express®

Author Information

  1. Brian Hoyle
  1. Ludwig Merker, MD
    1. Diabetes- und Nierenzentrum, Dormagen, Germany
View Full Text

Article usage

AbstractFullPDF
May 2015420
Aug 2015100
Oct 2015132
Total652

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Reductions in HbA1c and Weight in Type 2 Diabetics with the Empagliflozin Add-On Regimen
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Obesity
Diabetes Mellitus
Diabetes & Endocrinology Clinical Trials